MA Shokrgozar curriculum vitae

MA Shokrgozar curriculum vitae Jan 2013Professional interests:1- Hybridoma and recombinant monoclonal antibody production.2- Production of artificial and live tissue using biocompatible and biodegradable scaffolds and isolated cell fromdifferent tissues.3- Isolation and characterization of cells and stem cells isolated from different tissues for using in tissueengineering.4- Production and quality control of basic tissue engineering biomaterials from different tissues(collagen, …).5- Design and fabrication of some bio-systems for using in tissue engineering.6- Operation of different chemical and mechanical methods in differentiation of stem cells.7- Operation of different methods in evaluation of engineered living tissues.8- Operation of biocompatible and biodegradable tests.9- Operation of molecular and non-molecular methods in cell apoptosis diagnosis.10- Operation of different immunochemistry techniques and frequency analysis of specific B-lymphocytes inperipheral blood of immunized individuals.Publications:157- Ghavami M, Rezai M, Ejtehadi R, Lotfi M, Shokrgozar MA, Abd Emamy B, Raush J , Mahmoudi M.Physiological Temperature Has a Crucial Role in Amyloid Beta in the Absence and Presence of Hydrophobic andHydrophilic Nanoparticles. ACS Chem Neurosci 2013; In press. (ISI, Pubmed) (IF= 3.676)156- Hajiali H, Hosseinalipour M, Karbasi S, Shokrgozar MA. The influence of bioglass nanoparticles on thebiodegradation and biocompatibility of poly (3-hydroxybutyrate) scaffolds. Int J Artif Organs 2013; In press. (ISI,Pubmed) (IF=1.593)155- Akbarzadeh-Sharbaf S, Yakhchali B, Minuchehr Z, Shokrgozar MA, Zeinali Z. In silico design,construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin. AdvBiomed Res 2013; In press. (Pubmed)154- Sharifzadeh Z, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudi F, Jamnani FR, Moien MoghimiS. Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelidsingle domain antibodies as targeting agents. Cancer Lett 2013; In press. (ISI, Pubmed) (IF=4.238)153- Sharifzadeh Z, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudi F, Rahimi Jamnani F, AghaeeBakhtiari SH. Development of Oligoclonal Nanobodies for Targeting the Tumor-Associated Glycoprotein 72Antigen. Mol Biotechnol 2013; In press. (ISI, Pubmed) (IF=2.171)152- Mahmoudi M, Shokrgozar MA*, Behzadi S. Temperature Affects Cellular Uptakes/Toxicities of Nanoparticles.Nanoscale, 2013; In press. (ISI, Pubmed) (IF= 5.914)151- Bakhshi H, Yeganeh H, Mehdipour-Ataei S, Shokrgozar MA, Yari A, Seyyed Nasirodin Saeedi-Eslami SN.Synthesis and characterization of antibacterial polyurethane coatings from quaternary ammonium saltsfunctionalized soybean oil based polyols. Mater Sci Engin C 2013; 33: 153-164. (ISI) (IF= 2.686)14